Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
关于收到山东证监局警示函的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 瑞康医药集团股份有限公司 regarding receipt of a warning letter from the Shandong Securities Regulatory Bureau. It details regulatory violations related to failure to disclose related party transactions and major litigation in a timely manner, and the administrative regulatory measures taken against the company and certain executives. The document does not contain financial statements, audit results, or detailed financial data. It is a regulatory announcement about legal and compliance issues, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1683 characters), and it is a formal regulatory announcement rather than a report or presentation.
2023-12-29 Chinese
关于实际控制人部分股份质押的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the pledge of shares by the actual controller of the company, including details about the number of shares pledged, percentages, pledge terms, and assurances about the impact on company operations and control. It does not contain financial statements, audit results, or detailed financial performance data. It is a regulatory announcement about share pledging activity by major shareholders, which fits the category of a Major Shareholding Notification (MRQ). The document length is short (2063 characters) and it is not a report publication announcement or certification. Therefore, the appropriate classification is MRQ.
2023-12-29 Chinese
关于公司董事、监事、高管及相关管理团队增持计划的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a planned increase in shareholding by the company's directors, supervisors, and senior management team. It details the amount, purpose, method, and timing of the planned share purchases. There is no financial report, earnings data, or regulatory certification. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document is relatively short and focused solely on the shareholding increase plan by insiders, matching the 'Director's Dealing' category.
2023-12-22 Chinese
第五届监事会第五次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the fifth meeting of the fifth Supervisory Board of Ruikang Pharmaceutical Group Co., Ltd. It includes decisions on new guarantees and the proposed change of the company's auditing firm for 2023. The document references other announcements with specific announcement numbers and provides links to official disclosures. The content is about board/management decisions and approvals rather than the full audit report or financial statements. The document length is short (1318 characters) and it is an announcement of decisions rather than the audit report itself. Therefore, it fits best under Board/Management Information (MANG).
2023-12-20 Chinese
第五届董事会第一次独立董事专门会议审查意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding specific board meeting agenda items, including approval of a guarantee agreement and a change of the company's auditor. It references compliance with company law and stock exchange regulations, and it is signed by independent directors. The content is focused on board-level decisions and approvals rather than financial results or reports. There is no indication of full financial statements or detailed financial analysis. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions at the board level.
2023-12-20 Chinese
第五届董事会第五次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the fifth meeting of the fifth board of directors of Ruikang Pharmaceutical Group Co., Ltd. It includes details about board decisions such as approval of new guarantees, change of accounting firm, amendments to the independent director work system, and the proposal to convene an extraordinary general meeting. The document contains voting results and references to further disclosures but does not contain financial statements or detailed financial analysis. It is a formal announcement of board meeting decisions rather than a full management report or financial report. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2023-12-20 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.